Lirum Therapeutics is an innovative biopharmaceutical company focused on the treatment of debilitating diseases.
Lirum Therapeutics has raised $7.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2023.
Lirum Therapeutics is headquartered in Newyork, United Kingdom.
Lirum Therapeutics is an innovative biopharmaceutical company focused on the treatment of debilitating diseases.
Lirum Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lirum Therapeutics — Funding & Investors." VCBacked, February 8, 2023, https://www.vcbacked.co/company/lirum-therapeutics. Accessed August 13, 2026.
VCBacked. (2023). Lirum Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/lirum-therapeutics
{{cite web |title=Lirum Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/lirum-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated